Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'UNFRACTIONATED HEPARIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 902 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Samdani, S; Lachmann, E; Nagler, W
      Unilateral extremity swelling in female patients with cancer

      JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    2. Bittl, JA
      Editorial comment - From confusion to clarity: Direct thrombin inhibitors for patients with heparin-induced thrombocytopenia

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    3. Greer, IA; Thomson, AJ
      Management of venous thromboembolism in pregnancy

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    4. Alpert, JS; Budaj, AJ; Gurfinkel, EP; Henry, TD
      Issues in antithrombin therapy for UA/NSTEMI

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    5. Burrows, RF; Gan, ET; Gallus, AS; Wallace, EM; Burrows, EA
      A randomised double-blind placebo controlled trial of low molecular weightheparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    6. Lepercq, J; Conard, J; Borel-Derlon, A; Darmon, JY; Boudignat, O; Francoual, C; Priollet, P; Cohen, C; Yvelin, N; Schved, JF; Tournaire, M; Borg, JY
      Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    7. De Lorenzo, F; Noorani, A; Kakkar, VV
      Current trends in the management of thromboembolic events

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    8. Bell, GK; Goldhaber, SZ
      Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement

      VASCULAR MEDICINE
    9. Riedel, M
      Acute pulmonary embolism 2: treatment

      HEART
    10. Nicholson, CD; Lensing, AWA
      Old antithrombotics: ready to retire?

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    11. Kaiser, B; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    12. Groce, JB
      Treatment of deep vein thrombosis using low-molecular-weight heparins

      AMERICAN JOURNAL OF MANAGED CARE
    13. Spyropoulos, AC
      The use of a protocol for the treatment of deep vein thrombosis

      AMERICAN JOURNAL OF MANAGED CARE
    14. Arosio, E; Ferrari, G; Santoro, L; Gianese, F; Coccheri, S
      A placebo-controlled, double-blind study of mesoglycan in the treatment ofchronic venous ulcers

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    15. Turton, EPL; Coughlin, PA; Berridge, DC; Mercer, KG
      A survey of deep venous thrombosis management by consultant vascular surgeons in the United Kingdom and Ireland

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    16. Massicotte, MP
      Low-molecular-weight heparin therapy in children

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    17. Kher, A; Samama, MM
      Low-molecular-weight heparins: Weeks or months instead of days of treatment

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    18. Cella, G; Sbarai, A; Mazzaro, G; Motta, G; Carraro, P; Andreozzi, GM; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor release induced by defibrotide and heparins

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    19. Demir, M; Iqbal, O; Hoppensteadt, DA; Piccolo, P; Ahmad, S; Schultz, CL; Linhardt, RJ; Fareed, J
      Anticoagulant and antiprotease profiles of a novel natural heparinomimeticmannopentaose phosphate sulfate (PI-88)

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    20. Hakki, SI; Fareed, J; Hoppensteadt, DA; Abdullah, H; Camblin, J; Nasseri, AF; Hamadeh, O; Wright, T
      Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery (vol 6, pg 206, 2000)

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    21. Axelrod, DA; Wakefield, TW
      Future directions in antithrombotic therapy: Emphasis on venous thromboembolism

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    22. Hendel, RC
      Acute myocardial ischemia and infarction: Making the right decisions in antithrombotic and reperfusion therapies

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    23. Greer, IA
      The acute management of venous thromboembolism in pregnancy

      CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
    24. Money, SR; York, JW
      Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis

      CARDIOVASCULAR SURGERY
    25. Eikelboom, J; Baker, R
      Routine home treatment of deep vein thrombosis - Is now a reality

      BRITISH MEDICAL JOURNAL
    26. Schwarz, T; Schmidt, B; Hohlein, U; Beyer, J; Schroder, HE; Schellong, SM
      Eligibility for home treatment of deep vein thrombosis: prospective study

      BRITISH MEDICAL JOURNAL
    27. Malhotra, S; Bhargava, VK; Grover, A; Pandhi, P; Sharma, YP
      A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial)

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    28. Martin, M
      Treatment of deep vein thrombosis - a still unresolved problem

      PHLEBOLOGIE
    29. Koscielny, J
      Increase in liver enzyme levels during heparin therapy

      PHLEBOLOGIE
    30. Choo, JK; Kereiakes, DJ
      Low molecular weight heparin therapy for percutaneous coronary intervention: A practice in evolution

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    31. Merli, GJ; Vanscoy, GJ; Rihn, TL; Groce, JB; McCormick, W
      Applying scientific criteria to therapeutic interchange: A balanced analysis of low-molecular-weight heparins

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    32. Cohen, M
      The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    33. Krotenberg, R; Adler, U; Pomeranz, B; Miller, JD; Russell, MW
      Dalteparin vs. enoxaparin as prophylaxis for deep-vein thrombosis after total hip or knee arthroplasty - A retrospective analysis

      AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
    34. Murray, RD; Deitcher, SR; Shah, A; Jasper, SE; Bashir, M; Grimm, RA; Klein, AL
      Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation

      JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
    35. Andres, RL; Miles, A
      Venous thromboembolism and pregnancy

      OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
    36. Lewis, D; Allenet, B; Achkar, A; Elias, A; Khalife, K; Simonneau, G
      Tinzaparin for the treatment of acute pulmonary embolism: economic assessment of use in France

      PRESSE MEDICALE
    37. Belmin, J; Medjahed, S; Trivalle, C; Lutzer, P
      Heparin use and risk patterns in geriatric patients: a one-day audit in France

      PRESSE MEDICALE
    38. Gentric, A; Couturaud, F; Mottier, D
      Anticoagulants in the elderly - Indications

      PRESSE MEDICALE
    39. Sundrani, R; Klein, LW
      Antithrombotic and thrombolytic therapy in acute cardiac care

      CRITICAL CARE CLINICS
    40. Billett, HH
      Direct and indirect antithrombins - Heparins, low molecular weight heparins, heparinoids, and hirudin

      CLINICS IN GERIATRIC MEDICINE
    41. Heit, JA
      Prevention of venous thromboembolism

      CLINICS IN GERIATRIC MEDICINE
    42. Merli, GJ
      Treatment of deep venous thrombosis and pulmonary embolism with low molecular weight heparin in the geriatric patient population

      CLINICS IN GERIATRIC MEDICINE
    43. Lopez-Beret, P; Orgaz, A; Fontcuberta, J; Doblas, M; Martinez, A; Lozano, G; Romero, A
      Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis

      JOURNAL OF VASCULAR SURGERY
    44. Batchelor, WB; Mahaffey, KW; Berger, PB; Deutsch, E; Meier, S; Hasselblad, V; Fry, ET; Teirstein, PS; Ross, AM; Binanay, CA; Zidar, JP
      A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: The ATLAST trial

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    45. Hodl, R; Huber, K; Kraxner, W; Klein, W
      Limitation of vWf meta-analysis in LMWH comparison

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    46. Bahit, MC; Topol, EJ; Califf, RM; Armstrong, PW; Criger, DA; Hasselblad, V; Betriu, A; Hirsh, J; Ardissino, D; Granger, CB
      Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    47. Brown, DFM
      Treatment options for deep venous thrombosis

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    48. Edlow, JA
      Emergency department management of pulmonary embolism

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    49. Kleinschmidt, K; Charles, R
      Pharmacology of low molecular weight heparins

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    50. Shannon, AW; Harrigan, RA
      General pharmacologic treatment of acute myocardial infarction

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    51. Ginsberg, JS; Turpie, AGG
      Thromboembolism and pregnancy

      INTERNATIONAL ANGIOLOGY
    52. O'Shaughnessy, AM; Fitzgerald, DE
      An audit of the clinical and sub-clinical changes in the first year following an acute, deep vein thrombosis

      INTERNATIONAL ANGIOLOGY
    53. Neagu, M; Manda, G; Constantin, C; Tanaseanu, C; Mikhailidis, DP
      The in vitro effect of a low molecular weight heparin, nadroparin (Fraxiparine), on leukocytes obtained from patients with vascular disease

      INTERNATIONAL ANGIOLOGY
    54. Nicolaides, AN; Breddin, HK; Fareed, J; Goldhaber, S; Haas, S; Hull, R; Kalodiki, E; Myers, K; Samama, M; Sasahara, A
      Prevention of venous thromboembolism - International Consensus Statement -Guidelines compiled in accordance with the scientific evidence

      INTERNATIONAL ANGIOLOGY
    55. Baykal, C; Al, A; Demirtas, E; Ayhan, A
      Comparison of enoxaparin and standard heparin in gynaecologic oncologic surgery: A randomised prospective double-blind clinical study

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    56. Lai, KN; Ho, K; Cheung, RCK; Lit, LCW; Lee, SKM; Fung, KS; Tong, MKL; Lam, CWK
      Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    57. Vila, V; Martinez-Sales, V; Reganon, E; Peris, E; Perez, F; Ruano, M; Aznar, J
      Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes

      HAEMATOLOGICA
    58. Grau, E; Tenias, JM; Real, E; Medrano, J; Ferrer, R; Pastor, E; Selfa, S
      Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism

      AMERICAN JOURNAL OF HEMATOLOGY
    59. Auer, J; Berent, R; Maurer, E; Mayr, H; Weber, T; Eber, B
      Acute coronary syndromes - An update. Part I: Pathogenesis and drug therapy

      HERZ
    60. Huber, K; Niessner, A; Niessner, H
      Low molecular weight heparins in acute coronary syndrome

      HERZ
    61. Nenci, GG; Gresele, P; Ferrari, G; Santoro, L; Gianese, F
      Treatment of intermittent claudication with mesoglycan - A placebo-controlled, double-blind study

      THROMBOSIS AND HAEMOSTASIS
    62. Couturaud, F; Julian, JA; Kearon, C
      Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism - A meta-analysis

      THROMBOSIS AND HAEMOSTASIS
    63. Prandoni, P
      Heparins and venous thromboembolism: Current practice and future directions

      THROMBOSIS AND HAEMOSTASIS
    64. Warkentin, TE
      Heparin-induced thrombocytopenia: Yet another treatment paradox?

      THROMBOSIS AND HAEMOSTASIS
    65. Alban, S; Gastpar, R
      Plasma levels of total and free tissue factor pathway inhibitor (TFPI) as individual pharmacological parameters of various heparins

      THROMBOSIS AND HAEMOSTASIS
    66. Aschwanden, M; Labs, KH; Engel, H; Schwob, A; Jeanneret, C; Mueller-Brand, J; Jaeger, KA
      Acute deep vein thrombosis: Early mobilization does not increase the frequency of pulmonary embolism

      THROMBOSIS AND HAEMOSTASIS
    67. Partsch, H
      Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation

      VASA-JOURNAL OF VASCULAR DISEASES
    68. Wilson, SJ; Wilbur, K; Burton, E; Anderson, DR
      Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboembolism

      HAEMOSTASIS
    69. Todd, DW; Roman, A
      Outpatient use of low-molecular weight heparin in an anticoagulated patient requiring oral surgery: Case report

      JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
    70. Pineo, GF
      New developments in the prevention and treatment of venous thromboembolism

      PHARMACOTHERAPY
    71. Lopez, LM
      Low-molecular-weight heparins are essentially the same for treatment and prevention of venous thromboembolism

      PHARMACOTHERAPY
    72. Racine, E
      Differentiation of the low-molecular-weight heparins

      PHARMACOTHERAPY
    73. Wiggins, BS; Wittkowsky, AK; Nappi, JM
      Clinical use of new antithrombotic therapies for medical management of acute coronary syndromes

      PHARMACOTHERAPY
    74. Duplaga, BA; Rivers, CW; Nutescu, E
      Dosing and monitoring of low-molecular-weight heparins in special populations

      PHARMACOTHERAPY
    75. Noviasky, JA; Gaffney, BJ
      The "superiority" of enoxaparin for treatment of acute coronary syndromes

      PHARMACOTHERAPY
    76. Hoffman, R; Haim, N; Brenner, B
      Cancer and thrombosis revisited

      BLOOD REVIEWS
    77. Cohen, M
      The role of low-molecular-weight heparin in the management of acute coronary syndromes

      CURRENT OPINION IN CARDIOLOGY
    78. Chuang, P; Parikh, C; Reilly, RF
      A case review: Anticoagulation in hemodialysis patients with heparin-induced thrombocytopenia

      AMERICAN JOURNAL OF NEPHROLOGY
    79. Pottier, P; Blanchon, B; Pistorius, MA; Grolleau, JY
      Risk factors and incidence of venous thromboembolism in internal medicine:a prospective study on 947 in patients

      REVUE DE MEDECINE INTERNE
    80. Pautas, E; Siguret, V; d'Urso, M; Laurent, M; Gaussem, P; Fevrier, M; Durand-Gasselin, B
      Monitoring of tinzaparin treatment at treatment dose of 10 days in elderlypatients

      REVUE DE MEDECINE INTERNE
    81. Pollack, CV; Gibler, WB
      2000 ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A practical summary for emergency physicians

      ANNALS OF EMERGENCY MEDICINE
    82. Pollack, CV; Gibler, WB
      Advances create opportunities: Implementing the major tenets of the new unstable angina guidelines in the emergency department

      ANNALS OF EMERGENCY MEDICINE
    83. Vinson, DR; Berman, DA
      Outpatient treatment of deep venous thrombosis: A clinical care pathway managed by the emergency department

      ANNALS OF EMERGENCY MEDICINE
    84. Lancaster, GI; Lancaster, CJ; Radley, D; Cohen, M
      Prior aspirin use in unstable angina predisposes to higher risk: the aspirin paradox

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    85. Husted, S; Becker, R; Kher, A
      A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease

      CLINICAL CARDIOLOGY
    86. Verheugt, FWA; Chesebro, JH
      Acute coronary care and beyond: The expanding role of low-molecular-weightheparin

      CLINICAL CARDIOLOGY
    87. Fry, ETA
      Glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparins: A combined role in coronary interventions?

      CLINICAL CARDIOLOGY
    88. Chan, WS; Chunilal, SD; Ginsberg, JS
      Antithrombotic therapy during pregnancy

      SEMINARS IN PERINATOLOGY
    89. Rose, P; Bell, D; Green, ES; Davenports, A; Fegan, C; Grech, H; O'Shaughnessy, D; Voke, J
      The outcome of ambulatory DVT management using a multidisciplinary approach

      CLINICAL AND LABORATORY HAEMATOLOGY
    90. Bath, PMW; Lindenstrom, E; Boysen, G; De Deyn, P; Friis, P; Leys, D; Marttila, R; Olsson, JE; O'Neill, D; Orgogozo, JM; Ringelstein, B; van der Sande, JJ; Turpie, AGG
      Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial

      LANCET
    91. Bretschneider, E; Schror, K
      Cellular effects of factor Xa on vascular smooth muscle cells - Inhibitionby heparins?

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    92. Alban, S
      Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    93. Harenberg, J; Huisman, MV; Tolle, AR; Breddin, HK; Kirchmaier, CM
      Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    94. Boneu, B; de Moerloose, P
      How and when to monitor a patient treated with low molecular weight heparin

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    95. Weismantel, D
      Treatment of the patient with deep vein thrombosis

      JOURNAL OF FAMILY PRACTICE
    96. Shorr, AF; Ramage, AS
      Enoxaparin for thromboprophylaxis after major trauma: Potential cost implications

      CRITICAL CARE MEDICINE
    97. Goldhaber, SZ
      Unsolved issues in the treatment of pulmonary embolism

      THROMBOSIS RESEARCH
    98. Hofmann, S; Knoefler, R; Lorenz, N; Siegert, G; Wendisch, J; Mueller, D; Taut-Sack, H; Dinger, J; Kabus, M
      Clinical experiences with low-molecular weight heparins in pediatric patients

      THROMBOSIS RESEARCH
    99. Lee, AYY
      Treatment of venous thromboembolism in cancer patients

      THROMBOSIS RESEARCH
    100. Koch, A; Ziegler, S; Breitschwerdt, H; Victor, N
      Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: Meta-analysis based on original patient data

      THROMBOSIS RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 08:10:30